Afuresertib Completed Phase 2 Trials for Langerhans Cell Histiocytosis (LCH) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT01395004
A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis